Malarone

Malarone Dosage Calculator

(Prophylaxis for Adults)

Use to calculate the total number of Malarone (250/100) tablets required for your adult (>40kg) patient's trip.

The recommended dosage in adults for prophylaxis is one Malarone tablet (250/100) daily.

Input the date the patient enters and leaves the malaria-endemic area. The daily dose should be taken with food or milky drink at the same time each day. In the event of vomiting (within 1 hour of dosing), a repeat dose should be taken.

This tool is intended to assist healthcare professionals with calculating adult dosage recommendations for Malarone, based on one Malarone tablet (250/100) daily.

Select date of entry to malarious area

Select date leaving malarious area

Begin taking tablets 1 to 2 days prior to entering malarious area.
Take first tablet:

XX/YY/ZZ

Continue taking 1 tablet per day whilst in malarious area

XX days

Stop taking tablets 7 days after leaving malarious area.
Take final dose on:

XX/YY/ZZ

Packs of Malarone required

(24 tablets per pack)

Total number of tablets needed

Duration that patient would be taking Malarone1-3

XX

(1 tablet daily)

†Calculation based on starting 2 days prior to entering malarious area and 7 days after leaving malarious area

For information regarding use in children, please refer to the Malarone Junior (62.5/25) Product Information.

References:

  1. Malarone Approved Product Information.
  2. Centers for Disease Control and Prevention (CDC). Choosing a Drug to Prevent Malaria. Available from: www.cdc.gov/malaria/travelers/drugs.html (Accessed July 2022).
  3. World Health Organisation (WHO). International travel and health. Malaria: 2020 update. Available from: http://www.who.int/ith/en/ (Accessed July 2022).

PBS Information: Malarone is not listed on the PBS for malaria prophylaxis.

Authority required: Treatment of suspected or confirmed Plasmodium falciparum malaria in a patient aged 3 years or older where quinine containing regimens are inappropriate.

Please review Malarone Product Information before prescribing. For more information on this product please contact us. For more information on GSK products or to report an adverse event involving a GSK product, please contact GSK Medical Information on 1800 033 109. Trade marks are owned by or licensed to the GSK group of companies.
©2022 GSK group of companies or its licensor.

PM-AU-ATP-WCNT-200003
Date of Approval October 2022